Gene · 9261
Papers3,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer's Disease. | Int J Mol Sci | 2021 | 33808629 | PubTator, text mining | PubMed |
| Cytokines Stimulated by IL-33 in Human Skin Mast Cells: Involvement of NF-κB and p38 at Distinct Levels and Potent Co-Operation with FcεRI and MRGPRX2. | Int J Mol Sci | 2021 | 33808264 | PubTator, text mining | PubMed |
| Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues. | Cells | 2021 | 33808130 | PubTator, text mining | PubMed |
| Covalent Cysteine Targeting of Bruton's Tyrosine Kinase (BTK) Family by Withaferin-A Reduces Survival of Glucocorticoid-Resistant Multiple Myeloma MM1 Cells. | Cancers (Basel) | 2021 | 33807411 | PubTator, text mining | PubMed |
Articular Chondrocyte Phenotype Regulation through the Cytoskeleton and the Signaling Processes That Originate from or Converge on the Cytoskeleton: Towards a Novel Understanding of the Intersection between Actin Dynamics and Chondrogenic Function. | Int J Mol Sci | 2021 | 33807043 | PubTator, text mining | PubMed |
| Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing. | Cancers (Basel) | 2021 | 33806538 | PubTator, text mining | PubMed |
| Residual Disease in Glioma Recurrence: A Dangerous Liaison with Senescence. | Cancers (Basel) | 2021 | 33805316 | PubTator, text mining | PubMed |
| Prospects of Marine Sterols against Pathobiology of Alzheimer's Disease: Pharmacological Insights and Technological Advances. | Mar Drugs | 2021 | 33804766 | PubTator, text mining | PubMed |
| Multi-Omics Data Analysis Uncovers Molecular Networks and Gene Regulators for Metabolic Biomarkers. | Biomolecules | 2021 | 33801830 | PubTator, text mining | PubMed |
| Identifying Novel Drug Targets by iDTPnd: A Case Study of Kinase Inhibitors. | Genomics Proteomics Bioinformatics | 2021 | 33794377 | PubTator, text mining | PubMed |
| Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies. | Drug Des Devel Ther | 2021 | 33790539 | PubTator, text mining | PubMed |
| The roles of inducible chromatin and transcriptional memory in cellular defense system responses to redox-active pollutants. | Free Radic Biol Med | 2021 | 33789123 | PubTator, text mining | PubMed |
| The Roles of Neutrophils in the Pathogenesis of Liver Diseases. | Front Immunol | 2021 | 33763069 | PubTator, text mining | PubMed |
| Potential Role of Musashi-2 RNA-Binding Protein in Cancer EMT. | Onco Targets Ther | 2021 | 33762829 | PubTator, text mining | PubMed |
| Guidelines for Regulated Cell Death Assays: A Systematic Summary, A Categorical Comparison, A Prospective. | Front Cell Dev Biol | 2021 | 33748119 | PubTator, text mining | PubMed |
| Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer. | Gastroenterology | 2021 | 33745946 | PubTator, text mining | PubMed |
| The essential role of PRAK in tumor metastasis and its therapeutic potential. | Nat Commun | 2021 | 33741957 | PubTator, text mining | PubMed |
| Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage. | Virulence | 2021 | 33724154 | PubTator, text mining | PubMed |
| Kiaa0101 serves as a prognostic marker and promotes invasion by regulating p38/snail1 pathway in glioma. | Ann Transl Med | 2021 | 33708887 | PubTator, text mining | PubMed |
| Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells? | Transl Oncol | 2021 | 33684837 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9261/papers?page=47